ADAM9 Antikörper (Biotin)
Kurzübersicht für ADAM9 Antikörper (Biotin) (ABIN602623)
Target
Alle ADAM9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognizes human ADAM9 ectodomain.
-
Aufreinigung
- Immunoaffinity purified
-
Sterilität
- Sterile filtered
-
Immunogen
- NS0-derived, recombinant human ADAM9 ectodomain.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA (0.1 - 0.4 μg/mL), WB (0.1 - 0.2 μg/mL)
Usage: Suitable for use in ELISA and Western Blot. ELISA: 0.1-0.4 μg/mL. Western Blot: 0.1-0.2 μg/mL. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 40-50 % glycerol, PBS.
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from 0.2 um sterile-filtered solution in PBS, 50 μg BSA
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Lyophilized powder may be stored at 4°C for short-term only. Reconstituted product is stable for 1 year at -20°C.
-
-
- ADAM9 (ADAM Metallopeptidase Domain 9 (ADAM9))
-
Andere Bezeichnung
- ADAM9
-
Hintergrund
-
Name/Gene ID: ADAM9
Subfamily: Metallopeptidase M12B
Family: Protease
Synonyms: ADAM9, ADAM 9, CORD9, ADAM metallopeptidase domain 9, MCMP, Meltrin-gamma, Cone rod dystrophy 9, KIAA0021, MDC9, Mltng, Myeloma cell metalloproteinase -
Gen-ID
- 8754
-
UniProt
- Q13443
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, SARS-CoV-2 Protein Interaktom
Target
-